ABMD - Abiomed, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
262.16
+2.10 (+0.81%)
As of 10:54AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close260.06
Open259.03
Bid261.67 x 900
Ask262.01 x 800
Day's Range259.03 - 263.06
52 Week Range228.00 - 459.75
Volume74,348
Avg. Volume708,258
Market Cap11.871B
Beta (3Y Monthly)1.03
PE Ratio (TTM)46.73
EPS (TTM)5.61
Earnings DateAug 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est334.38
Trade prices are not sourced from all markets
  • A Closer Look At Abiomed, Inc.'s (NASDAQ:ABMD) Impressive ROE
    Simply Wall St.3 hours ago

    A Closer Look At Abiomed, Inc.'s (NASDAQ:ABMD) Impressive ROE

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Markit2 days ago

    See what the IHS Markit Score report has to say about Abiomed Inc.

    Abiomed Inc NASDAQ/NGS:ABMDView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for ABMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding ABMD are favorable, with net inflows of $8.11 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire7 days ago

    Abiomed First Quarter Fiscal 2020 Earnings and Conference Call Notification

    The Company will host a conference call to discuss the results on Thursday, August 1, 2019, at 8:00 a.m. EDT. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call.

  • Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign
    Investor's Business Daily8 days ago

    Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign

    Medical technology companies are rising bullishly in 2019. The best-performing medical stocks tend to have high Composite Ratings, reflecting strong growth metrics vs. all other stocks.

  • Here's What Abiomed, Inc.'s (NASDAQ:ABMD) ROCE Can Tell Us
    Simply Wall St.17 days ago

    Here's What Abiomed, Inc.'s (NASDAQ:ABMD) ROCE Can Tell Us

    Today we'll evaluate Abiomed, Inc. (NASDAQ:ABMD) to determine whether it could have potential as an investment idea...

  • Need To Know: Abiomed, Inc. (NASDAQ:ABMD) Insiders Have Been Selling Shares
    Simply Wall St.17 days ago

    Need To Know: Abiomed, Inc. (NASDAQ:ABMD) Insiders Have Been Selling Shares

    We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

  • 3 Top Healthcare Stocks to Buy
    Motley Fool19 days ago

    3 Top Healthcare Stocks to Buy

    Find out why Cardinal Health, CannTrust Holdings, and Abiomed have our healthcare experts feeling giddy right now.

  • New Strong Sell Stocks for June 27th
    Zacks21 days ago

    New Strong Sell Stocks for June 27th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • New Strong Sell Stocks for June 19th
    Zacks29 days ago

    New Strong Sell Stocks for June 19th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • IART vs. ABMD: Which Stock Should Value Investors Buy Now?
    Zackslast month

    IART vs. ABMD: Which Stock Should Value Investors Buy Now?

    IART vs. ABMD: Which Stock Is the Better Value Option?

  • Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women’s Health
    Business Wirelast month

    Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women’s Health

    Abiomed’s (ABMD) Impella platform is being featured today at a Washington, D.C., event showcasing innovations in medical technology that improve healthcare for women. Abiomed’s participation supports its Women’s Initiative for Heart Recovery, which provides education and raises awareness of women’s cardiovascular diseases and the opportunity for heart recovery. One young woman who benefited from heart recovery with Impella support is Iman Dorty, who is speaking at today’s event.

  • Hedge Funds Have Never Been This Bullish On ABIOMED, Inc. (ABMD)
    Insider Monkeylast month

    Hedge Funds Have Never Been This Bullish On ABIOMED, Inc. (ABMD)

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • Abiomed, Inc. (NASDAQ:ABMD): Will The Growth Last?
    Simply Wall St.last month

    Abiomed, Inc. (NASDAQ:ABMD): Will The Growth Last?

    Abiomed, Inc.'s (NASDAQ:ABMD) latest earnings announcement in March 2019 showed that the business benefited from a...

  • New Strong Sell Stocks for June 5th
    Zackslast month

    New Strong Sell Stocks for June 5th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • Not Just Uber: 5 Stocks Analysts Love Unanimously
    Investor's Business Dailylast month

    Not Just Uber: 5 Stocks Analysts Love Unanimously

    Uber shares are popping today on word analysts practically all love the stock. But turns out, it's not the only stock showered with "buy" ratings from analysts. The question, though, is whether that should matter to investors.

  • Why Is Abiomed (ABMD) Up 0.6% Since Last Earnings Report?
    Zacks2 months ago

    Why Is Abiomed (ABMD) Up 0.6% Since Last Earnings Report?

    Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Abiomed (ABMD) Dips More Than Broader Markets: What You Should Know
    Zacks2 months ago

    Abiomed (ABMD) Dips More Than Broader Markets: What You Should Know

    Abiomed (ABMD) closed the most recent trading day at $261.92, moving -1.68% from the previous trading session.

  • Business Wire2 months ago

    Abiomed to Present at Upcoming Investor Conferences

    Abiomed, Inc. , a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer

  • GuruFocus.com2 months ago

    Abiomed Inc (ABMD) Files 10-K for the Fiscal Year Ended on March 31, 2019

    Abiomed Inc (NASDAQ:ABMD) files its latest 10-K with SEC for the fiscal year ended on March 31, 2019.

  • ABIOMED Gets FDA Confirmation of the Safety of Impella RP
    Zacks2 months ago

    ABIOMED Gets FDA Confirmation of the Safety of Impella RP

    ABIOMED (ABMD) receives the FDA confirmation of the safety and effectiveness of the company's Impella RP heart pump.

  • FDA clears Abiomed heart pump after concerns over death rate
    American City Business Journals2 months ago

    FDA clears Abiomed heart pump after concerns over death rate

    Months after federal regulators warned doctors that one of the heart pumps made by Danvers’ Abiomed could be linked to a higher rate of death than previously thought, the company’s device has been cleared by the FDA.

  • Top 5 S&P 500 Stocks for 2018 by Performance
    Investopedia2 months ago

    Top 5 S&P 500 Stocks for 2018 by Performance

    The Standard & Poor's 500 index—commonly called the S&P 500, or simply the S&P—is the primary gauge of the large-cap U.S. equities market. It is based on the market capitalization figures of the top 500 companies that list their common stock on the NYSE or NASDAQ. Based on available historical data, the S&P has generated an average annual return of around 9.8% from 1928 through 2016.

  • Business Wire2 months ago

    FDA Confirms Impella RP is Safe and Effective; Only Right-Sided Device with FDA Approval

    Use of early identification protocol leads to higher survival and native heart recovery, as demonstrated in FDA studies

  • National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery
    Business Wire2 months ago

    National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery

    Improves upon AMI cardiogenic shock historical survival of 50%